When started in a 28-month-old patient with homozygous SCN1B-associated early infantile DEE, fenfluramine led to a cessation of fever-induced status epilepticus and a reduction in seizure frequency and severity. This evidence concerns the gene SCN1B and developmental and epileptic encephalopathy.